Все публикации

0:07:10

An Integrated Approach and Strategies to Mitigate Immunogenicity Risk

0:05:59

Evaluating immunogenicity risk of complex peptide products

0:05:19

Pro5 MHC Class I Pentamers

0:05:48

Ankyrons: the future of target-binding reagents beyond antibodies

0:18:58

Akshay Binayke: Proinflammatory cytokines & metabolomic signatures shape T cell response in COVID-19

0:20:08

Hoyoung Lee: IL-15-induced bystander activation of memory CD8+ T cells in acute viral infection

0:21:20

Mastering Immunity 2023 Infectious Diseases Expert Symposium: Expert Panel Discussion 2

0:18:38

Toru Okamoto: Development of an engineered ACE2 decoy for the treatment of COVID-19

0:21:32

Maike Hofmann: CD8+ T cell memory in chronic viral hepatitis

0:18:15

Jeremy Fry: Ankyrons: The future of target-binding reagents beyond antibodies

0:26:46

Daniela Weiskopf: Immune responses induced by SARS-CoV-2 vaccination

0:22:31

Mastering Immunity 2023 Infectious Diseases Expert Symposium: Expert Panel Discussion 1

0:20:24

Helen Wagstaffe: Kinetics & phenotype of T cells after SARS-CoV-2 challenge of seronegative adults

0:25:08

Mike Zimmer: Engineering a less immunogenic bacterial protease for treatment of IgA Nephropathy

0:16:08

Andrew Isidoridy: Evaluating immunogenicity risk of complex peptide products

0:27:07

Kei Kishimoto: Amplifying the effect of antigen-specific tolerogenic ImmTOR nanoparticle

0:25:30

Kuan Rong Chan: Characterisation of host immune variations influencing responses to YF vaccine

0:24:58

Steven Nadler: Centyrin: siRNA conjugates – a novel modality for the treatment of human disease

0:52:05

Timothy Hickling: Immunogenicity of biotherapeutics: why do we care and where do we stand

0:22:35

David Ulaeto: Therapeutic potential of humanised Ab to treat Venezuelan Equine Encephalitis Virus

0:36:47

Robin Thorpe: European Regulatory Guidance for Unwanted Immunogenicity

0:25:47

Heather Hinton: Pre Clinical Risk Assessment Technologies

0:17:09

Global SARS-CoV-2 Expert Symposium 2022: Panel Discussion 2

0:20:50

Paul Klenerman: PITCH: Covid-19 immunity studies in a UK Health Care Worker Cohort